Uncategorized
FDA asks for more data on Lilly’s Foundayo to assess heart, liver risks
The FDA is concerned that Eli Lilly’s newly approved obesity pill Foundayo might come with a risk for major cardiovascular events and liver damage, and has asked the company to provide data …